Clinical Utility of Genomic Assay in Node-Positive Early-Stage Breast Cancer.
Breast cancer (BC) is the most common malignancy among women in Canada. Adjuvant treatment in early BC can reduce the risk of BC recurrence. Historically, the decision for adjuvant chemotherapy for early BC was made only based on clinical and tumour characteristics. In recent years, there has been a...
| Publicado en: | Current Oncology Vol. 29; no. 7; pp. 5139 - 5150 |
|---|---|
| Autores principales: | , |
| Formato: | Journal Article |
| Publicado: |
MDPI
Jul2022
|
| Acceso en línea: | Ver este registro en EBSCOhost |